Clopidogrel (Plavix), a P2Y12receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo

Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study

(2012) N. R. Jørgensen et al.   JOURNAL OF INTERNAL MEDICINE

The P2Y6Receptor Stimulates Bone Resorption by Osteoclasts

(2011) Isabel R. Orriss et al.   ENDOCRINOLOGY

Purinergic signalling and bone remodelling☆

(2010) Isabel R Orriss et al.   CURRENT OPINION IN PHARMACOLOGY

Purinergic regulation of cytosolic calcium and phosphoinositide metabolism in rat osteoblast-like osteosarcoma cells

(2010) Hiromichi Kumagai et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts

(2010) W.B. Bowler et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical P2X7 receptor pharmacology in two human osteoblast-like cell lines

(2009) SM Alqallaf et al.   BRITISH JOURNAL OF PHARMACOLOGY

Expression, signaling, and function of P2X7 receptors in bone

(2009) Matthew W. Grol et al.   Purinergic Signalling

P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis

(2008) Nattapon Panupinthu et al.   JOURNAL OF CELL BIOLOGY

Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts

(2008) S. Armstrong et al.   JOURNAL OF CELL SCIENCE